Biotin-labeled M1-20 could bind to endogenous Foxm1 from mouse breast cancer 4T1 cell lysates (Supplemental Fig. 8B) and as expected, M1-20 inhibited 4T1 cells at a dose-dependent manner (Supplemental Fig. 8C). This evidence concerns the gene FOXM1 and breast carcinoma.